PLoS ONE · 2008 · 2.6K citations · 9 references
Life SciencesBiotechnologyMolecular BiologyGenetic EngineeringRecombinant Dna TechnologyRecombinationMolecular CloningPlasmid BiologyPlasmid EngineeringRecombinant Plasmid ConstructionRestriction Enzyme TechnologySite-specific RecombinationCloningHomologous Recombination-based CloningPlasmid CloningRecombination-based CloningRestriction Enzyme DigestionRestriction Site DesignType Ii Restriction EnzymesType Iis Restriction Enzymes
Site‑specific recombination cloning is efficient and flexible but leaves unwanted 8–13 amino acid tags in the expressed protein. The authors aim to create a rapid subcloning strategy that transfers DNA fragments without leaving residual recombination sites. The method uses type IIs restriction enzymes with engineered cleavage sites so that two fragments can be ligated into a product lacking the original restriction site. Golden Gate cloning yields nearly 100 % correct plasmids in a single 5‑minute reaction, matching recombination‑based methods while eliminating unwanted sequences.
Current cloning technologies based on site-specific recombination are efficient, simple to use, and flexible, but have the drawback of leaving recombination site sequences in the final construct, adding an extra 8 to 13 amino acids to the expressed protein. We have devised a simple and rapid subcloning strategy to transfer any DNA fragment of interest from an entry clone into an expression vector, without this shortcoming. The strategy is based on the use of type IIs restriction enzymes, which cut outside of their recognition sequence. With proper design of the cleavage sites, two fragments cut by type IIs restriction enzymes can be ligated into a product lacking the original restriction site. Based on this property, a cloning strategy called 'Golden Gate' cloning was devised that allows to obtain in one tube and one step close to one hundred percent correct recombinant plasmids after just a 5 minute restriction-ligation. This method is therefore as efficient as currently used recombination-based cloning technologies but yields recombinant plasmids that do not contain unwanted sequences in the final construct, thus providing precision for this fundamental process of genetic manipulation.
9
Anatoli Giritch, Sylvestre Marillonnet, Carola Engler et al. · Proceedings of the National Academy of Sciences · 2006 · 421 citations · Full text
Sylvestre Marillonnet, Anatoli Giritch, Mario Gils et al. · Proceedings of the National Academy of Sciences · 2004 · 364 citations · Full text